Weight loss goals may be at the forefront of many New Year's resolutions, which could push the exuberance for Eli Lilly (LLY) and Novo Nordisk (NVO) stock.

Hyderabad: Eli Lilly and Company, a multinational pharmaceutical company, announced plans to establish a new global ...

US pharma company Eli Lilly plans to open a new global capability centre in Hyderabad by mid-2025. It will recruit over 1,000 ...

The ₹8,500 crore order from Eli Lilly and Company is a testament to Remedium Lifecares capabilities and its growing ...

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

Remedium Lifecare is well-positioned to capitalize on the opportunities presented by this landmark deal.

Mumbai: Indian pharmaceutical company Remedium Lifecare Limited, listed under BSE Code 539561, has recently achieved a major milestone. According to sources, the company has received a massive order ...

Colulintide is under clinical development by Eli Lilly and Co and currently in Phase I for Obesity. According to GlobalData, Phase I drugs for Obesity have a 59% phase transition success rate (PTSR) ...

LY-4052031 is under clinical development by Eli Lilly and Co and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase I drugs for Ovarian Cancer have a 73% phase transition success ...

Indian pharmaceutical company Remedium Lifecare Limited, listed on the BSE Code 539561, has recently made a significant achievement. The company has received a massive order worth ₹8,500 crore from ...

It considers the safety, efficacy and, most importantly, the cost-benefit of new pharmaceuticals ... set by Eli Lilly for the use of Mounjaro in type 2 diabetes is any marker, the company is ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.